Please provide your email address to receive an email when new articles are posted on . In this issue of Cardiology Today’s Intervention, we have a packed issue with a lot of great content. The Cover ...
On the heels of STRIDE, one of the first trials to show glucagon-like peptide-1 (GLP-1) receptor agonists can help patients with PAD, a retrospective study of more than 100,000 patients provides more ...
Compliance 360 deg results presented by Dr. Raymond Dattilo show superior outcomes at six months for peripheral arterial disease patients treated with CSI's device. St. Paul, MN & San Francisco, CA ...
The field of adult stem cell plasticity is developing so rapidly that terminology is lagging. Most tissues or organ systems have a stem cell compartment to repair damage or replace aged cells.
JACKSONVILLE, Florida — If you have not heard of peripheral artery disease, you are not alone. While physicians and health organizations have made headway in raising awareness that heart disease is ...
ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) today announced that CBSET, a not-for-profit preclinical research institute dedicated to biomedical research ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk ...
Hosted on MSN
Patients with peripheral arterial disease and Afib found to face higher risk for cardiac events
Credit: Intermountain Health New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results